Some specialty drugs offer good value for both patients and payers. However, as payers are left with fewer options to manage the cost of specialty drugs, additional transparency of cost trends and clinical efficacy is needed to develop comprehensive solutions. Additionally, greater competition is needed among specialty pharmacies to ensure greater pricing transparency and competition. The next fact sheet in this series will further explore options for payers through plan management strategies.
This fact sheet focuses on specialty drugs, conditions requiring specialty drugs, and factors influencing costs.
